Bimoxyl LA 150 mg/ml Suspension for Injection

Страна: Ірландія

мова: англійська

Джерело: HPRA (Health Products Regulatory Authority)

Активний інгредієнт:

Amoxicillin trihydrate

Доступна з:

Bimeda Animal Health Limited

Код атс:

QJ01CA04

ІПН (Міжнародна Ім'я):

Amoxicillin trihydrate

Дозування:

150 milligram(s)/millilitre

Фармацевтична форма:

Suspension for injection

Тип рецепту:

POM: Prescription Only Medicine as defined in relevant national legislation

Терапевтична области:

amoxicillin

Статус Авторизація:

Authorised

Дата Авторизація:

1987-10-01

Характеристики продукта

Bimoxyl LA SPC IRL page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF VETERINARY MEDICINAL PRODUCT:
Bimoxyl LA 150mg/ml Suspension for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION.
Active Substance
Each ml contains 150mg Amoxicillin
(as Amoxicillin trihydrate PhEur.)
For full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for injection.
A cream to off-white oily suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, sheep, pigs and dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle: For the control and treatment of respiratory and other
infections caused by
amoxicillin susceptible Gram-positive and Gram-negative bacteria only.
Sheep, Pigs and Dogs: For the treatment of infectious diseases in
pigs, sheep and
dogs, caused by or associated with organisms sensitive to amoxicillin.
4.3
CONTRAINDICATIONS
Not suitable for intravenous or intrathecal administration.
Not to be administered to small herbivores.
Not for use in ewes producing milk for human consumption or food
processing.
Do not use in known cases of hypersensitivity to penicillin or the
active ingredient.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS.
None known.
Bimoxyl LA SPC IRL page 2 of 5
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
PRODUCT TO
ANIMALS
Penicillins and Cephalosporins may cause hypersensitivity (allergy)
following
injection, inhalation, ingestion or skin contact.
Hypersensitivity to penicillins may lead to cross-reactions to
cephalosporins and vice
versa. Allergic reactions to these substances may occasionally be
serious.
Do not handle this product if you know you are sensitised or if you
have been advised
not to work with such preparations.
If you develop symptoms following exposure such as a skin rash, you
should seek
medical advice and show the doctor this warning. Swelling of the face,
lips and eyes
or difficulty with breathing are more serious symptoms and require
urgent